Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ZARS Pharma Inc.
This study will evaluate the analgesic efficacy of the matrix fentanyl patch. The study will be conducted in non-opioid tolerant patients with moderate to severe osteoarthritis (OA) pain. This patient population was chosen in anticipation that the patients are otherwise healthy adults being treated with NSAIDs (Nonsteroidal Anti-inflammatory Drugs) or acetaminophen or who have received intermittent opioid analgesic treatment.
Age
40–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults between the ages of 40 and 75 years of age suffering from moderate to severe chronic pain caused by osteoarthritis.
You may not be if
Patient is already taking chronic opioids or has a history of substance abuse or has a substance abuse disorder.
Clareo Health | Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain
